Related references
Note: Only part of the references are listed.Head and neck squamous cell carcinoma
Daniel E. Johnson et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Validation of the Brandwein Gensler Risk Model in Patients of Oral Cavity Squamous Cell Carcinoma in North India
Arun Chaturvedi et al.
HEAD & NECK PATHOLOGY (2020)
STAT3-and GSK3-mediated Mcl-1 regulation modulates TPF resistance in oral squamous cell carcinoma
Santanu Maji et al.
CARCINOGENESIS (2019)
MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation
Lingtao Jin et al.
CANCER CELL (2018)
Tumor suppressive role for kinases phosphorylating p53 in DNA damage-induced apoptosis
Satomi Yogosawa et al.
CANCER SCIENCE (2018)
PRICKLE1 Contributes to Cancer Cell Dissemination through Its Interaction with mTORC2
Avais M. Daulat et al.
DEVELOPMENTAL CELL (2016)
Targeting cancer with kinase inhibitors
Stefan Gross et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Neoadjuvant chemotherapy in oral cancers: Selecting the right patients
S. Vishak et al.
INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY (2015)
Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment
Bernard Leroy et al.
HUMAN MUTATION (2014)
Lestaurtinib, a multitargeted tyrosinse kinase inhibitor: from bench to bedside
Munira Shabbir et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
The regulation of p53 by phosphorylation: A model for how distinct signals Integrate into the p53 pathway
Nicola J. Maclaine et al.
AGING-US (2009)
Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders
Elizabeth O. Hexner et al.
BLOOD (2008)
A phase 2 trial of the FLT3 inhibitor lestaurtinib (CEP701) as first-line treatment for older patients with acute myeloid leukemia not considered fit for intensive chemotherapy
Steven Knapper et al.
BLOOD (2006)
A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus
LD Mayo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular cloning of MINK, a novel member of mammalian GCK family kinases, which is up-regulated during postnatal mouse cerebral development
I Dan et al.
FEBS LETTERS (2000)
Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53
LSS John et al.
CANCER GENE THERAPY (2000)
Share Paper
